{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:03:28Z","timestamp":1790373808570,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in patients with end-stage liver disease (ESLD), particularly in the perioperative and posttransplant periods. Despite its critical impact, cardiovascular risk assessment and management strategies remain inconsistent across institutions. This review provides a timely synthesis of recent findings, highlighting the need for standardized cardiovascular evaluation and optimization in ESLD patients undergoing liver transplantation (LT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Emerging data emphasize the interplay between cirrhosis, portal hypertension, systemic inflammation, and cardiovascular dysfunction, contributing to cirrhotic cardiomyopathy, coronary artery disease, arrhythmias, and heart failure. Advances in pretransplant screening suggest a shift toward risk-stratified approaches, integrating noninvasive imaging and selective coronary angiography. Intraoperative and postoperative cardiovascular complications remain prevalent, with immunosuppressive therapy exacerbating long-term CVD risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A multidisciplinary approach to cardiovascular management in ESLD patients is essential to improving LT outcomes. Standardized preoperative protocols, refined risk stratification, and evidence-based postoperative monitoring are critical to reducing CVD-related complications. Future research should focus on optimizing cardiovascular interventions, developing consensus guidelines, and improving long-term cardiovascular care in LT recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aco.0000000000001509","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:05:57Z","timestamp":1750082757000},"page":"498-502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative cardiovascular assessment and management of liver transplant patients"],"prefix":"10.1097","volume":"38","author":[{"given":"Ali O.","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Salah","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyna","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","article-title":"Liver disease is a significant risk factor for cardiovascular outcomes \u2013 a UK Biobank study.","volume":"79","author":"Roca-Fernandez","year":"2023","journal-title":"J Hepatol"},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.114.009278","article-title":"Prevalence and prediction of coronary artery disease in patients with liver cirrhosis.","volume":"130","author":"An","year":"2014","journal-title":"Circulation"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s11606-023-08199-z","article-title":"Association between end-stage liver disease and incident heart failure in an integrated health system.","volume":"38","author":"Chuzi","year":"2023","journal-title":"J Gen Intern Med"},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/lt.23950","article-title":"High early cardiovascular mortality following liver transplantation.","volume":"20","author":"VanWagner","year":"2014","journal-title":"Liver Transplant"},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOT.0000000000000614","article-title":"Understanding and managing cardiovascular outcomes in liver transplant recipients.","volume":"24","author":"Izzy","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"1 Suppl","key":"R7-20250819","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension.","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccc.2016.02.004","article-title":"The circulatory system in liver disease.","volume":"32","author":"Hollenberg","year":"2016","journal-title":"Crit Care Clin"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension.","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"21 Suppl 1","key":"R10-20250819","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor.","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","article-title":"Cirrhotic cardiomyopathy.","volume":"56","author":"Zardi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5049.174870","article-title":"Preoperative cardiovascular investigations in liver transplant candidate: an update.","volume":"60","author":"Sehgal","year":"2016","journal-title":"Indian J Anaesth"},{"key":"R13-20250819","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"R14-20250819","doi-asserted-by":"crossref","DOI":"10.14218\/JCTH.2024.00226","article-title":"Risk of coronary artery disease in patients with liver cirrhosis: a systematic review and meta-analysis.","volume":"000","author":"Gu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"R15-20250819","first-page":"100528","article-title":"Cardiology assessment of patients undergoing evaluation for orthotopic liver transplantation.","volume":"2","author":"Lee","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","article-title":"Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.","volume":"98","author":"Tiukinhoy-Laing","year":"2006","journal-title":"Am J Cardiol"},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31083\/j.rcm2303091","article-title":"Cardiovascular events after liver transplantation: MACE hurts.","volume":"23","author":"Altieri","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"R18-20250819","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1093\/eurheartj\/ehae502","article-title":"Cardiovascular disease assessment and management in liver transplantation.","volume":"45","author":"Harinstein","year":"2024","journal-title":"Eur Heart J"},{"key":"R19-20250819","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/hep.31647","article-title":"Cardiac risk assessment in liver transplant candidates: current controversies and future directions.","volume":"73","author":"Barman","year":"2021","journal-title":"Hepatology"},{"key":"R20-20250819","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ctr.12643","article-title":"Patent foramen ovale in liver transplant recipients does not negatively impact short\u2010term outcomes.","volume":"30","author":"Werlang","year":"2016","journal-title":"Clin Transplant"},{"key":"R21-20250819","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1056\/NEJMoa041905","article-title":"Coronary-artery revascularization before elective major vascular surgery.","volume":"351","author":"McFalls","year":"2004","journal-title":"N Engl J Med"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/bjaed\/mkw031","article-title":"Anaesthesia for liver transplantation.","volume":"17","author":"Kashimutt","year":"2017","journal-title":"BJA Education"},{"key":"R23-20250819","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/lt.23427","article-title":"Anesthesia for liver transplantation in US academic centers: institutional structure and perioperative care.","volume":"18","author":"Walia","year":"2012","journal-title":"Liver Transpl"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jclinane.2013.04.017","article-title":"Anesthesia for liver transplantation in United States academic centers: intraoperative practice.","volume":"25","author":"Schumann","year":"2013","journal-title":"J Clin Anesth"},{"key":"R25-20250819","first-page":"1372","article-title":"Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery.","volume":"78","author":"Feltracco","year":"2012","journal-title":"Minerva Anestesiol"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T18:01:52Z","timestamp":1755626512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001509","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]}}}